Cipla reported INR15.2 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q4 Mar/2026 10.94 15.10 May/08
FY2026Q3 Dec/2025 11.20 14.92 19.43 Jan/23
FY2026Q1 Sep/2025 16.72 15.33 16.12 Oct/29
FY2026Q1 Jun/2025 16.06 14.87 14.57 Jul/25
FY2025Q4 Mar/2025 15.10 12.29 11.62 May/12




Eps Change Date
Arca Biopharma USD -0.54 0.14 Dec/2025
aTyr Pharma USD 0.53 0.8 Dec/2025
Bio Path USD -0.07 0.48 Sep/2025
Brainstorm Cell Therapeutics USD -0.19 0.15 Sep/2025
Capricor Therapeutics USD -0.62 0.08 Dec/2025
Cara Therapeutics USD -0.59 4.45 Sep/2025
Cipla INR 15.2 1.52 Dec/2025
Dr.Reddys Laboratories INR 14.52 2.98 Dec/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Immunic USD -0.24 0.03 Sep/2024
Infinity Pharmaceuticals USD -0.11 0.01 Jun/2023
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sun Pharmaceuticals INR 12.8 0.2 Dec/2025
TherapeuticsMD USD -0.09 0.02 Jun/2024
UPL INR 4.69 2.11 Dec/2025